623 related articles for article (PubMed ID: 30031766)
1. Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.
Zhang P; Samuel G; Crow J; Godwin AK; Zeng Y
Transl Res; 2018 Nov; 201():136-153. PubMed ID: 30031766
[TBL] [Abstract][Full Text] [Related]
2. Molecular confirmation of Ewing sarcoma.
Dagher R; Pham TA; Sorbara L; Kumar S; Long L; Bernstein D; Mackall C; Raffeld M; Tsokos M; Helman L
J Pediatr Hematol Oncol; 2001 May; 23(4):221-4. PubMed ID: 11846300
[TBL] [Abstract][Full Text] [Related]
3. Ewing sarcoma family of tumors.
Khoury JD
Adv Anat Pathol; 2005 Jul; 12(4):212-20. PubMed ID: 16096383
[TBL] [Abstract][Full Text] [Related]
4. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.
Athale UH; Shurtleff SA; Jenkins JJ; Poquette CA; Tan M; Downing JR; Pappo AS
J Pediatr Hematol Oncol; 2001 Feb; 23(2):99-104. PubMed ID: 11216714
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
6. Primary Ewing sarcoma of the stomach--a newly described entity.
Rafailidis S; Ballas K; Psarras K; Pavlidis T; Symeonidis N; Marakis G; Sakadamis A
Eur Surg Res; 2009; 42(1):17-20. PubMed ID: 18971581
[TBL] [Abstract][Full Text] [Related]
7. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
[TBL] [Abstract][Full Text] [Related]
8. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
[TBL] [Abstract][Full Text] [Related]
9. Review: Ewing Sarcoma Predisposition.
Gargallo P; Yáñez Y; Juan A; Segura V; Balaguer J; Torres B; Oltra S; Castel V; Cañete A
Pathol Oncol Res; 2020 Oct; 26(4):2057-2066. PubMed ID: 31656020
[TBL] [Abstract][Full Text] [Related]
10. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
11. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
[TBL] [Abstract][Full Text] [Related]
12. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
13. Extraskeletal Ewing's sarcoma in a 67-year-old man.
Hanaoka N; Goto T; Kasai T; Matsuura T; Nishisho T; Enishi T; Yasui N
J Orthop Sci; 2011 Mar; 16(2):250-2. PubMed ID: 21327980
[No Abstract] [Full Text] [Related]
14. Primary Ewing sarcoma of the brain: a case report and literature review.
Kazmi SA; Perry A; Pressey JG; Wellons JC; Hammers Y; Palmer CA
Diagn Mol Pathol; 2007 Jun; 16(2):108-11. PubMed ID: 17525681
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a Child.
Daley J; Williams N; Salgado CM; Schultz C; Meade J; Ozolek J; Lindsey B; Bailey KM
J Pediatr Hematol Oncol; 2022 Nov; 44(8):486-488. PubMed ID: 35426856
[TBL] [Abstract][Full Text] [Related]
16. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
17. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
18. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
19. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
20. Adamantinoma-like Ewing sarcoma of the thyroid.
Jones R; Maleki Z
Diagn Cytopathol; 2020 Dec; 48(12):E4-E6. PubMed ID: 32558347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
